Orchid Pharma Limited — Important, 05-08-2025: Updates

Orchid Pharma has secured a significant strategic victory. A French court has ruled in the company's favor, approving the acquisition of assets from Allecra Therapeutics SAS. This pivotal development empowers Orchid Pharma to integrate new capabilities and strengthens its pipeline. This asset purchase marks a significant step forward in the company's business development, potentially opening new avenues for growth and enhancing its market position. Investors should monitor future updates on the integration and financial impact.